The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/36592
StudyName: Eligibility Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas With no Available Potentially NCT02030834
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 24.05.2019
License: Creative Commons BY 4.0

----

Description: 
Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT02030834
